Biocon Executive Chair Kiran Mazumdar-Shaw said expiring biologic patents could help the company expand affordable cancer biosimilars and rise beyond its current top-five global ranking, while AI could shorten clinical trials by predicting safety…

Oct 15, 2026 - 04:25
 0  0

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0